SOAT1 and cancer: Given their central role in promoting cancer cell survival, invasion, therapy resistance and immunosuppression via multiple mechanisms, molecules that target proteins of the STAT family are being utilized to develop novel modulators of the pathway, including JAK inhibitors, STAT inhibitors and SOCS mimetics [74, 75], as well as histone deacetylase inhibitors [76].